Richard Slansky
2016 - OncoSec Medical
In 2016, Richard Slansky earned a total compensation of $878K as Chief Financial Officer at OncoSec Medical, a 4,229% increase compared to previous year.
Compensation breakdown
| Option Awards | $402,119 |
|---|---|
| Salary | $273,898 |
| Stock Awards | $202,000 |
| Total | $878,017 |
Slansky received $402.1K in option awards, accounting for 46% of the total pay in 2016.
Slansky also received $273.9K in salary and $202K in stock awards.
Rankings
In 2016, Richard Slansky's compensation ranked 8,855th out of 14,075 executives tracked by ExecPay. In other words, Slansky earned more than 37.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,855 out of 14,075 | 37th |
Division Manufacturing | 3,426 out of 5,486 | 38th |
Major group Chemicals And Allied Products | 1,161 out of 1,900 | 39th |
Industry group Drugs | 914 out of 1,543 | 41st |
Industry Pharmaceutical Preparations | 728 out of 1,173 | 38th |
Source: SEC filing on November 28, 2017.
Slansky's colleagues
We found four more compensation records of executives who worked with Richard Slansky at OncoSec Medical in 2016.